$1.59 Billion is the total value of ARMISTICE CAPITAL, LLC's 61 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 69.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Sell | SPDR S&P 500 ETF TRput | $395,550,000 | -12.5% | 1,350,000 | -15.6% | 24.94% | +0.8% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $42,762,000 | -19.7% | 408,000 | -4.0% | 2.70% | -7.5% |
| CELG | Sell | CELGENE CORP | $36,976,000 | -33.8% | 400,000 | -32.4% | 2.33% | -23.7% |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $25,478,000 | -13.3% | 936,000 | -39.1% | 1.61% | -0.2% |
| FTDR | Sell | FRONTDOOR INC | $21,775,000 | -44.1% | 500,000 | -55.8% | 1.37% | -35.6% |
| ATRS | Sell | ANTARES PHARMA INC | $19,740,000 | -36.7% | 6,000,000 | -41.7% | 1.24% | -27.1% |
| ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $16,740,000 | -14.2% | 2,700,000 | -1.6% | 1.06% | -1.2% |
| TGT | Sell | TARGET CORP | $8,055,000 | -74.9% | 93,000 | -76.8% | 0.51% | -71.1% |
| BIIB | Sell | BIOGEN INC | $6,548,000 | -81.5% | 28,000 | -81.3% | 0.41% | -78.7% |
| ALIM | Sell | ALIMERA SCIENCES INC | $5,194,000 | -29.4% | 5,836,000 | -15.9% | 0.33% | -18.7% |
| SBBP | Sell | STRONGBRIDGE BIOPHARMA PLC | $4,945,000 | -60.2% | 1,580,000 | -36.6% | 0.31% | -54.1% |
| BLPH | Sell | BELLEROPHON THERAPEUTICS INC | $1,714,000 | -9.5% | 2,860,000 | -1.4% | 0.11% | +3.8% |
| ALRN | Sell | AILERON THERAPEUTICS INC | $864,000 | -86.3% | 1,200,000 | -62.9% | 0.05% | -84.3% |
| MBRX | Exit | MOLECULIN BIOTECH INC | $0 | – | -220,598 | -100.0% | -0.01% | – |
| NAKD | Exit | NAKED BRAND GROUP LIMITED | $0 | – | -1,462,150 | -100.0% | -0.02% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -1,560,000 | -100.0% | -0.15% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -80,000 | -100.0% | -0.16% | – |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -1,780,000 | -100.0% | -0.17% | – |
| TSN | Exit | TYSON FOODS INCcl a | $0 | – | -52,000 | -100.0% | -0.20% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.22% | – |
| PETQ | Exit | PETIQ INC | $0 | – | -158,000 | -100.0% | -0.27% | – |
| VLRX | Exit | VALERITAS HLDGS INC | $0 | – | -19,900,000 | -100.0% | -0.36% | – |
| OLLI | Exit | OLLIES BARGAIN OUTLT HLDGS I | $0 | – | -80,000 | -100.0% | -0.37% | – |
| EAT | Exit | BRINKER INTL INC | $0 | – | -164,000 | -100.0% | -0.40% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -2,500,000 | -100.0% | -0.40% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -90,000 | -100.0% | -0.42% | – |
| NKE | Exit | NIKE INCcl b | $0 | – | -108,000 | -100.0% | -0.50% | – |
| FUN | Exit | CEDAR FAIR L Pdepositry unit | $0 | – | -200,000 | -100.0% | -0.58% | – |
| CPB | Exit | CAMPBELL SOUP CO | $0 | – | -332,000 | -100.0% | -0.69% | – |
| FIZZ | Exit | NATIONAL BEVERAGE CORP | $0 | – | -248,000 | -100.0% | -0.78% | – |
| DKS | Exit | DICKS SPORTING GOODS INC | $0 | – | -400,000 | -100.0% | -0.81% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.82% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -1,928,000 | -100.0% | -1.13% | – |
| HD | Exit | HOME DEPOT INC | $0 | – | -112,000 | -100.0% | -1.18% | – |
| CPB | Exit | CAMPBELL SOUP COcall | $0 | – | -600,000 | -100.0% | -1.25% | – |
| SJM | Exit | SMUCKER J M COcall | $0 | – | -200,000 | -100.0% | -1.28% | – |
| PLYA | Exit | PLAYA HOTELS & RESORTS NV | $0 | – | -3,580,000 | -100.0% | -1.50% | – |
| AZO | Exit | AUTOZONE INC | $0 | – | -28,000 | -100.0% | -1.57% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -1,500,000 | -100.0% | -1.78% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -1,072,000 | -100.0% | -2.23% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -2,100,000 | -100.0% | -2.85% | – |
| CVS | Exit | CVS HEALTH CORPcall | $0 | – | -1,250,000 | -100.0% | -4.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.